Viatris

Health Care Pharmaceuticals Pittsburgh, Pennsylvania Last filing Feb 26, 2026 · FY2025

                    Revenue
                    FY2025
                
$14.3B
                    3y CAGR -4.2%
                    
                    P8
                    
                    -3.0%
                    
                    Net income
                    FY2025
                
$-3.5B
                    Net margin -24.7%
                    
                    P3
                    
                    -454.2%
                    
                    Total assets
                    FY2025
                
$37.2B
                    ROA -9.5%
                    
                    P3
                    
                    -10.4%
                    
                    Operating cash flow
                    FY2025
                
$2.3B
                    FCF margin +13.6%
                    
                    P39
                    
                    +0.6%

10 yrs · FY2016–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s total assets.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 3 years

Total assets $37.2B

Total liabilities $22.5B

Shareholders equity $14.7B

Account	2025	2024	2023
Assets
Cash and Cash Equivalents	3.6%	1.8%	2.1%
Accounts Receivable	8.2%	7.8%	7.8%
Inventory	10.8%	9.3%	7.3%
Prepaid Expenses	3.9%	4.1%	4.3%
Other Current Assets	0.4%	0.9%	0.6%
Total Current Assets	26.3%	22.9%	27.2%
Property,Plant and Equipment	7.0%	6.4%	5.8%
Operating Lease Assets	0.7%	0.6%	0.5%
Goodwill	18.2%	22.0%	20.7%
Intangible Assets	40.6%	41.1%	40.2%
Deferred Tax Assets	2.9%	1.8%	1.5%
Other Noncurrent Assets	5.0%	5.7%	4.6%
Total Assets	100.0%	100.0%	100.0%
Liabilities
Accounts Payable	4.7%	4.5%	4.1%
Accrued Liabilities	2.1%	2.8%	1.9%
Current Portion of Long Term Debt	5.2%	0.0%	4.1%
Operating Lease Liabilities	0.3%	0.2%	0.2%
Other Current Liabilities	8.8%	9.0%	7.1%
Total Current Liabilities	19.1%	13.9%	16.3%
Long Term Debt	33.6%	33.8%	33.9%
Operating Lease Liabilities Noncurrent	0.5%	0.4%	0.3%
Deferred Tax Liabilities	2.4%	2.7%	3.6%
Other Noncurrent Liabilities	5.4%	4.7%	3.2%
Total Liabilities	60.4%	55.1%	57.1%
Equity
Common Stock	0.0%	0.0%	0.0%
Additional Paid In Capital	50.6%	45.6%	39.5%
Retained Earnings	-1.0%	8.2%	9.7%
Treasury Stock	2.7%	1.2%	0.5%
Accumulated Other Comprehensive Income	-7.3%	-7.7%	-5.8%
Total Stockholders Equity	39.6%	44.9%	42.9%
Total Liabilitiesand Equity	100.0%	100.0%	100.0%

Income Statement

Revenue, expense, and profitability

17 accounts · 3 years

Revenue $14.3B

Operating income $-2.7B

Net income $-3.5B

Account	2025	2024	2023
IncomeStatement
Revenues Total Revenue	38.3%	35.4%	32.3%
Expenses Cost of Revenue	25.0%	22.0%	18.8%
Expenses Research and Development	2.6%	1.9%	1.7%
Expenses Selling,General and Administrative	10.2%	9.9%	8.5%
Expenses Depreciation and Amortization	7.5%	7.0%	5.7%
Expenses Share Based Compensation	0.5%	0.4%	0.4%
Expenses Operating Expenses	20.6%	13.5%	11.9%
Other Income Expense Gross Profit	13.5%	13.6%	13.5%
Other Income Expense Operating Income	-7.2%	0.0%	1.6%
Other Income Expense Interest Expense	1.3%	1.3%	1.2%
Other Income Expense Other Income/expense	-1.4%	-0.2%	0.0%
Other Income Expense Income Before Tax	-9.9%	-1.5%	0.4%
Income Tax Income Tax Expense	-0.4%	0.0%	0.3%
net Income net Income	-9.5%	-1.5%	0.1%
net Income Comprehensive Income	1.4%	-1.1%	0.0%
Earnings Per Share Basic Eps	-0.0%	-0.0%	0.0%
Earnings Per Share Diluted Eps	-0.0%	-0.0%	0.0%

Cash Flow Statement

Operating, investing, and financing flows

24 accounts · 3 years

Operating cash flow $2.3B

Investing cash flow $-427.7M

Financing cash flow $-1.3B

Account	2025	2024	2023
CashFlow
Operating Activities net Income	-9.5%	-1.5%	0.1%
Operating Activities Depreciation and Amortization	7.5%	7.0%	5.7%
Operating Activities Stock Based Compensation	0.5%	0.4%	0.4%
Operating Activities Deferred Income Taxes	-1.3%	-1.8%	-0.8%
Operating Activities Changes In Operating Assets and Liabilities	-0.6%	1.0%	1.1%
Operating Activities net Cash From Operating Activities	6.2%	5.5%	6.1%
Investing Activities Capital Expenditures	1.0%	0.8%	0.8%
Investing Activities Business Acquisitions	0.0%	0.8%	1.4%
Investing Activities Purchases of Investments	0.1%	0.1%	0.1%
Investing Activities Proceeds From Sale of Investments	0.1%	0.1%	0.1%
Investing Activities Other Investing Activities	0.1%	0.1%	0.2%
Investing Activities net Cash From Investing Activities	-1.1%	4.3%	-1.8%
Financing Activities Proceeds From Debt	0.0%	0.0%	0.0%
Financing Activities Repayment of Debt	0.0%	8.9%	2.6%
Financing Activities Repurchase of Common Stock	1.3%	0.6%	0.5%
Financing Activities Dividends Paid	1.6%	1.4%	1.2%
Financing Activities Proceeds From Stock Issuance	0.0%	0.0%	0.0%
Financing Activities Tax Withholding On Stock Based Compensation	0.1%	0.1%	0.1%
Financing Activities Other Financing Activities	-0.5%	0.7%	-0.4%
Financing Activities net Cash From Financing Activities	-3.5%	-10.4%	-4.8%
Cash Reconciliation Effect of Exchange Rate On Cash	0.0%	-0.1%	-0.0%
Cash Reconciliation net Change In Cash	1.6%	-0.6%	-0.6%
Cash Reconciliation Cash At Beginning of Period	3.6%	1.8%	2.1%
Cash Reconciliation Cash At End of Period	3.6%	1.8%	2.1%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 3 years

Ratio	2025	2024	2023
Profitability
Gross margin	+34.8%	+38.0%	+41.6%
Operating margin	-18.7%	+0.1%	+5.0%
Net margin	-24.7%	-4.3%	+0.4%
FCF margin	+13.6%	+13.5%	+16.4%
Growth
Revenue CAGR (3y)	-4.2%	-6.2%	+9.2%
Returns
ROE	-23.9%	-3.4%	+0.3%
ROA	-9.5%	-1.5%	+0.1%
ROIC	-9.6%	+0.0%	+0.5%
Liquidity
Current ratio	1.38x	1.65x	1.67x
Quick ratio	0.61x	0.68x	0.60x
Leverage
D/E	1.53x	1.23x	1.33x
Interest coverage	-5.65x	0.02x	1.34x
Efficiency
Asset turnover	0.38x	0.35x	0.32x
Cash conversion cycle	+166d	+160d	+150d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

Viatris

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history